What to expect from different drugs used in the treatment of COVID-19: a study on applications and in vivo and in vitro results

Página do item simplificado
dc.creatorMarcolino, Vanessa Aparecida
dc.creatorPimentel, Tatiana Colombo
dc.creatorBarão, Carlos Eduardo
dc.date.accessioned2020-09-21T14:14:07Z
dc.date.available2020-09-21T14:14:07Z
dc.date.issued2020-11
dc.description.abstractThe end of 2019 was marked by the emergence of a new type of coronavirus (SARS-CoV-2), which has killed more than 240,000 people around the world so far. Several clinical studies are being performed to test possible drugs in response to the COVID-19 outbreak; however, there is still no treatment that is completely effective. Our goal in this paper is to bring together the results of main studies carried out with different drugs in order to help spread the knowledge about possible treatments for COVID-19 that have been suggested so far.pt_BR
dc.identifier.citationMARCOLINO, V. A.; PIMENTEL, T. C.; BARÃO, C. E. What to expect from different drugs used in the treatment of COVID-19: a study on applications and in vivo and in vitro results. European Journal of Pharmacology, [S.l.], v. 887, Nov. 2020.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/43151
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0014299920305598#!pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsopenAccesspt_BR
dc.sourceEuropean Journal of Pharmacologypt_BR
dc.subjectChloroquinept_BR
dc.subjectAntiviralspt_BR
dc.subjectDexamethasonept_BR
dc.subjectIvermectinpt_BR
dc.subjectAnticoagulantspt_BR
dc.titleWhat to expect from different drugs used in the treatment of COVID-19: a study on applications and in vivo and in vitro resultspt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição:
Baixar

Coleções

FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)